{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T04:33:12Z","timestamp":1775622792773,"version":"3.50.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,3]],"date-time":"2022-10-03T00:00:00Z","timestamp":1664755200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,10,3]],"date-time":"2022-10-03T00:00:00Z","timestamp":1664755200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"National University of Singapore Yong Loo Lin School of Medicine's Junior Academic Faculty Scheme"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"DOI":"10.1007\/s11239-022-02713-6","type":"journal-article","created":{"date-parts":[[2022,10,3]],"date-time":"2022-10-03T16:02:46Z","timestamp":1664812966000},"page":"83-91","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Ischaemic events in hypertrophic cardiomyopathy patients with and without atrial fibrillation: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"55","author":[{"given":"Tiffany T. S.","family":"Ye","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi Zhuang","family":"Siah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin Y. Q.","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamie S. Y.","family":"Ho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas L. X.","family":"Syn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yao Hao","family":"Teo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yao Neng","family":"Teo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James W.","family":"Yip","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiong-Cheng","family":"Yeo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiqin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raymond C. C.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Chai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vijay Kumar","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonard L. L.","family":"Yeo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2764-2869","authenticated-orcid":false,"given":"Ching-Hui","family":"Sia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,10,3]]},"reference":[{"key":"2713_CR1","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/jhg.2015.83","volume":"61","author":"A Kimura","year":"2016","unstructured":"Kimura A (2016) Molecular genetics and pathogenesis of cardiomyopathy. J Hum Genet 61:41\u201350. https:\/\/doi.org\/10.1038\/jhg.2015.83","journal-title":"J Hum Genet"},{"key":"2713_CR2","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1161\/01.CIR.92.4.785","volume":"92","author":"BJ Maron","year":"1995","unstructured":"Maron BJ, Gardin JM, Flack JM, Gidding SS, Kurosaki TT, Bild DE (1995) Prevalence of hypertrophic cardiomyopathy in a general population of young adults: echocardiographic analysis of 4111 subjects in the CARDIA study. Circulation 92:785\u2013789. https:\/\/doi.org\/10.1161\/01.CIR.92.4.785","journal-title":"Circulation"},{"key":"2713_CR3","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.ijcard.2018.08.038","volume":"273","author":"YJ Choi","year":"2018","unstructured":"Choi YJ, Choi EK, Do HK, Jung JH, Park J, Lee E et al (2018) Temporal trends of the prevalence and incidence of atrial fibrillation and stroke among Asian patients with hypertrophic cardiomyopathy: a nationwide population-based study. Int J Cardiol 273:130\u2013135. https:\/\/doi.org\/10.1016\/j.ijcard.2018.08.038","journal-title":"Int J Cardiol"},{"key":"2713_CR4","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1002\/ejhf.316","volume":"17","author":"OP Guttmann","year":"2015","unstructured":"Guttmann OP, Pavlou M, O\u2019Mahony C, Monserrat L, Anastasakis A, Rapezzi C et al (2015) Prediction of thrombo-embolic risk in patients with hypertrophic cardiomyopathy (HCM Risk-CVA). Eur J Heart Fail 17:837\u2013845. https:\/\/doi.org\/10.1002\/ejhf.316","journal-title":"Eur J Heart Fail"},{"key":"2713_CR5","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/S0140-6736(12)60397-3","volume":"381","author":"BJ Maron","year":"2013","unstructured":"Maron BJ, Maron MS (2013) Hypertrophic cardiomyopathy. Lancet 381:242\u2013255. https:\/\/doi.org\/10.1016\/S0140-6736(12)60397-3","journal-title":"Lancet"},{"key":"2713_CR6","doi-asserted-by":"publisher","first-page":"727","DOI":"10.7150\/ijms.50167","volume":"18","author":"L Liu","year":"2021","unstructured":"Liu L, Liu Z, Chen X, He S (2021) Thromboembolism in patients with hypertrophic cardiomyopathy. Int J Med Sci 18:727\u2013735. https:\/\/doi.org\/10.7150\/ijms.50167","journal-title":"Int J Med Sci"},{"key":"2713_CR7","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1161\/STROKEAHA.115.012130","volume":"47","author":"S Haruki","year":"2016","unstructured":"Haruki S, Minami Y, Hagiwara N (2016) Stroke and embolic events in hypertrophic cardiomyopathy: risk stratification in patients without atrial fibrillation. Stroke 47:936\u2013942. https:\/\/doi.org\/10.1161\/STROKEAHA.115.012130","journal-title":"Stroke"},{"key":"2713_CR8","doi-asserted-by":"publisher","DOI":"10.18632\/aging.102532","author":"TT Lin","year":"2019","unstructured":"Lin TT, Sung YL, Ko TY, Lee CK, Lin LY, Juang JJM et al (2019) Risk of ischemic stroke in patients with hypertrophic cardiomyopathy in the absence of atrial fibrillation - a nationwide cohort study. Aging (Albany NY). https:\/\/doi.org\/10.18632\/aging.102532","journal-title":"Aging (Albany NY)"},{"key":"2713_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s12947-016-0072-5","author":"VM Parato","year":"2016","unstructured":"Parato VM, Antoncecchi V, Sozzi F, Marazia S, Zito A, Maiello M et al (2016) Echocardiographic diagnosis of the different phenotypes of hypertrophic cardiomyopathy. Cardiovasc Ultrasound. https:\/\/doi.org\/10.1186\/s12947-016-0072-5","journal-title":"Cardiovasc Ultrasound"},{"key":"2713_CR10","doi-asserted-by":"publisher","first-page":"87","DOI":"10.2302\/kjm.2018-0004-OA","volume":"68","author":"Y Aizawa","year":"2019","unstructured":"Aizawa Y, Tanimoto Y, Hirata Y, Fujisawa T, Fukuoka R, Nakajima K et al (2019) Incidence, clinical characteristics, and long-term outcome of the dilated phase of hypertrophic cardiomyopathy. Keio J Med 68:87\u201394. https:\/\/doi.org\/10.2302\/kjm.2018-0004-OA","journal-title":"Keio J Med"},{"key":"2713_CR11","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.chest.2018.11.009","volume":"155","author":"H Jung","year":"2019","unstructured":"Jung H, Yang PS, Jang E, Yu HT, Kim TH, Uhm JS et al (2019) Effectiveness and safety of non-vitamin k antagonist oral anticoagulants in patients with atrial fibrillation with hypertrophic cardiomyopathy: a nationwide cohort study. Chest 155:354\u2013363. https:\/\/doi.org\/10.1016\/j.chest.2018.11.009","journal-title":"Chest"},{"key":"2713_CR12","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.21037\/atm-20-1817","volume":"8","author":"H-J Lee","year":"2020","unstructured":"Lee H-J, Kim H-K, Kim M, Moon I, Lee H, Kim B-S et al (2020) Clinical impact of atrial fibrillation in a nationwide cohort of hypertrophic cardiomyopathy patients. Ann Transl Med 8:1386\u20131386. https:\/\/doi.org\/10.21037\/atm-20-1817","journal-title":"Ann Transl Med"},{"key":"2713_CR13","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1136\/heartjnl-2016-310720","volume":"103","author":"SE Lee","year":"2017","unstructured":"Lee SE, Park JK, Uhm JS, Kim JY, Pak HN, Lee MH et al (2017) Impact of atrial fibrillation on the clinical course of apical hypertrophic cardiomyopathy. Heart 103:1496\u20131501. https:\/\/doi.org\/10.1136\/heartjnl-2016-310720","journal-title":"Heart"},{"key":"2713_CR14","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1016\/j.amjcard.2011.07.024","volume":"108","author":"J Moon","year":"2011","unstructured":"Moon J, Shim CY, Ha JW, Cho IJ, Kang MK, Yang WI et al (2011) Clinical and echocardiographic predictors of outcomes in patients with apical hypertrophic cardiomyopathy. Am J Cardiol 108:1614\u20131619. https:\/\/doi.org\/10.1016\/j.amjcard.2011.07.024","journal-title":"Am J Cardiol"},{"key":"2713_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.repc.2017.08.005","volume":"37","author":"N Cardim","year":"2018","unstructured":"Cardim N, Brito D, Rocha Lopes L, Freitas A, Ara\u00fajo C, Belo A et al (2018) The portuguese registry of hypertrophic cardiomyopathy: overall results. Rev Port Cardiol 37:1\u201310. https:\/\/doi.org\/10.1016\/j.repc.2017.08.005","journal-title":"Rev Port Cardiol"},{"key":"2713_CR16","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.jjcc.2013.10.011","volume":"63","author":"B Yashiro","year":"2014","unstructured":"Yashiro B, Minami Y, Terajima Y, Hagiwara N (2014) Prognostic difference between paroxysmal and non-paroxysmal atrial fibrillation in patients with hypertrophic cardiomyopathy. J Cardiol 63:432\u2013437. https:\/\/doi.org\/10.1016\/j.jjcc.2013.10.011","journal-title":"J Cardiol"},{"key":"2713_CR17","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.ijcard.2017.05.019","volume":"240","author":"K Kanbayashi","year":"2017","unstructured":"Kanbayashi K, Minami Y, Haruki S, Maeda R, Itani R, Ashihara K et al (2017) Association of elevated pulmonary artery systolic pressure with stroke and systemic embolic events in patients with hypertrophic cardiomyopathy. Int J Cardiol 240:320\u2013323. https:\/\/doi.org\/10.1016\/j.ijcard.2017.05.019","journal-title":"Int J Cardiol"},{"key":"2713_CR18","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1007\/s11739-020-02275-6","volume":"15","author":"Z Wang","year":"2020","unstructured":"Wang Z, Liao H, Chen X, He S (2020) Hyperuricemia: risk factor for thromboembolism in hypertrophic cardiomyopathy patients. Intern Emerg Med 15:1231\u20131237. https:\/\/doi.org\/10.1007\/s11739-020-02275-6","journal-title":"Intern Emerg Med"},{"key":"2713_CR19","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1253\/circj.CJ-19-0936","volume":"84","author":"A Hohneck","year":"2020","unstructured":"Hohneck A, Overhoff D, Doesch C, Sandberg R, Rudic B, Tueluemen E et al (2020) Extent of late gadolinium enhancement predicts thromboembolic events in patients with hypertrophic cardiomyopathy. Circ J 84:754\u2013762. https:\/\/doi.org\/10.1253\/circj.CJ-19-0936","journal-title":"Circ J"},{"key":"2713_CR20","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1016\/j.cjca.2019.05.035","volume":"35","author":"S He","year":"2019","unstructured":"He S, Wang Z, Cheem TH, Liao H, Chen X, He Y (2019) External validation of the model of thromboembolic risk in hypertrophic cardiomyopathy patients. Can J Cardiol 35:1800\u20131806. https:\/\/doi.org\/10.1016\/j.cjca.2019.05.035","journal-title":"Can J Cardiol"},{"key":"2713_CR21","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1016\/j.amjcard.2018.08.040","volume":"122","author":"HG van Velzen","year":"2018","unstructured":"van Velzen HG, Schinkel AFL, Baart SJ, Huurman R, van Slegtenhorst MA, Kardys I et al (2018) Effect of gender and genetic mutations on outcomes in patients with hypertrophic cardiomyopathy. Am J Cardiol 122:1947\u20131954. https:\/\/doi.org\/10.1016\/j.amjcard.2018.08.040","journal-title":"Am J Cardiol"},{"key":"2713_CR22","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1007\/s00380-015-0718-5","volume":"31","author":"YJ Yang","year":"2016","unstructured":"Yang YJ, Yuan JQ, Fan CM, Pu JL, Fang PH, Ma J et al (2016) Incidence of ischemic stroke and systemic embolism in patients with hypertrophic cardiomyopathy, nonvalvular atrial fibrillation, CHA2DS2-VASc score of \u22641 and without anticoagulant therapy. Heart Vessels 31:1148\u20131153. https:\/\/doi.org\/10.1007\/s00380-015-0718-5","journal-title":"Heart Vessels"},{"key":"2713_CR23","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1159\/000092590","volume":"106","author":"CH Lee","year":"2006","unstructured":"Lee CH, Liu PY, Lin LJ, Chen JH, Tsai LM (2006) Clinical features and outcome of patients with apical hypertrophic cardiomyopathy in Taiwan. Cardiology 106:29\u201335. https:\/\/doi.org\/10.1159\/000092590","journal-title":"Cardiology"},{"key":"2713_CR24","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.amjms.2015.10.006","volume":"351","author":"Y Xiao","year":"2016","unstructured":"Xiao Y, Wang LP, Yang YK, Tian T, Yang KQ, Sun X et al (2016) Clinical profile and prognosis of left ventricular apical aneurysm in hypertrophic cardiomyopathy. Am J Med Sci 351:101\u2013110. https:\/\/doi.org\/10.1016\/j.amjms.2015.10.006","journal-title":"Am J Med Sci"},{"key":"2713_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12872-018-0984-0","volume":"19","author":"N Songsirisuk","year":"2019","unstructured":"Songsirisuk N, Kittipibul V, Methachittiphan N, Charoenattasil V, Zungsontiporn N, Spanuchart I et al (2019) Modes of death and clinical outcomes in adult patients with hypertrophic cardiomyopathy in Thailand. BMC Cardiovasc Disord 19:1\u20139. https:\/\/doi.org\/10.1186\/s12872-018-0984-0","journal-title":"BMC Cardiovasc Disord"},{"key":"2713_CR26","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1253\/jcj.61.673","volume":"61","author":"M Higashikawa","year":"1997","unstructured":"Higashikawa M, Nakamura Y, Yoshida M, Kinoshita M (1997) Incidence of ischemic strokes in hypertrophic cardiomyopathy is markedly increased if complicated by atrial fibrillation. Jpn Circ J 61:673\u2013681. https:\/\/doi.org\/10.1253\/jcj.61.673","journal-title":"Jpn Circ J"},{"key":"2713_CR27","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1159\/000354953","volume":"126","author":"T Tian","year":"2013","unstructured":"Tian T, Wang Y, Sun K, Wang J, Zou Y, Zhang W et al (2013) Clinical profile and prognostic significance of atrial fibrillation in hypertrophic cardiomyopathy. Cardiol 126:258\u2013264. https:\/\/doi.org\/10.1159\/000354953","journal-title":"Cardiol"},{"key":"2713_CR28","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1536\/ihj.27.475","volume":"27","author":"S Kogure","year":"1986","unstructured":"Kogure S, Yamamoto Y, Tomono S, Hasegawa A, Suzuki T (1986) High risk of systemic embolism in hypertrophic cardiomyopathy. Jpn Heart J 27:475\u2013480. https:\/\/doi.org\/10.1536\/ihj.27.475","journal-title":"Jpn Heart J"},{"key":"2713_CR29","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/S0735-1097(01)01727-2","volume":"39","author":"BJ Maron","year":"2002","unstructured":"Maron BJ, Olivotto I, Bellone P, Conte MR, Cecchi F, Flygenring BP et al (2002) Clinical profile of stroke in 900 patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 39:301\u2013307. https:\/\/doi.org\/10.1016\/S0735-1097(01)01727-2","journal-title":"J Am Coll Cardiol"},{"key":"2713_CR30","doi-asserted-by":"publisher","first-page":"2420","DOI":"10.1161\/CIRCULATIONAHA.117.029267","volume":"136","author":"EJ Rowin","year":"2017","unstructured":"Rowin EJ, Hausvater A, Link MS, Abt P, Gionfriddo W, Wang W et al (2017) Clinical profile and consequences of atrial fibrillation in hypertrophic cardiomyopathy. Circulation 136:2420\u20132436. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.117.029267","journal-title":"Circulation"},{"key":"2713_CR31","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.echo.2011.03.002","volume":"24","author":"J Binder","year":"2011","unstructured":"Binder J, Attenhofer Jost CH, Klarich KW, Connolly HM, Tajik AJ, Scott CG et al (2011) Apical hypertrophic cardiomyopathy: prevalence and correlates of apical outpouching. J Am Soc Echocardiogr 24:775\u2013781. https:\/\/doi.org\/10.1016\/j.echo.2011.03.002","journal-title":"J Am Soc Echocardiogr"},{"key":"2713_CR32","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1007\/s100380200021","volume":"47","author":"A Ogimoto","year":"2002","unstructured":"Ogimoto A, Hamada M, Nakura J, Miki T, Hiwada K (2002) Relation between angiotensin-converting enzyme II genotype and atrial fibrillation in Japanese patients with hypertrophic cardiomyopathy. J Hum Genet 47:184\u2013189. https:\/\/doi.org\/10.1007\/s100380200021","journal-title":"J Hum Genet"},{"issue":"2","key":"2713_CR33","first-page":"988","volume":"35","author":"M Li","year":"2007","unstructured":"Li M, Wang QB, Cheng K (2007) Long term follow-up results of 199 patients with hypertrophic cardiomyopathy. Zhonghua Xin Xue Guan Bing Za Zhi Chinese J Cardiovasc Dis 35(2):988\u2013991","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi Chinese J Cardiovasc Dis"},{"key":"2713_CR34","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1016\/j.amjcard.2014.01.435","volume":"113","author":"P Spirito","year":"2014","unstructured":"Spirito P, Autore C, Formisano F, Assenza GE, Biagini E, Haas TS et al (2014) Risk of sudden death and outcome in patients with hypertrophic cardiomyopathy with benign presentation and without risk factors. Am J Cardiol 113:1550\u20131555. https:\/\/doi.org\/10.1016\/j.amjcard.2014.01.435","journal-title":"Am J Cardiol"},{"key":"2713_CR35","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1253\/circj.CJ-19-0186","volume":"83","author":"T Hirota","year":"2019","unstructured":"Hirota T, Kubo T, Baba Y, Ochi Y, Takahashi A, Yamasaki N et al (2019) Clinical profile of thromboembolic events in patients with hypertrophic cardiomyopathy in a regional Japanese cohort - results from Kochi RYOMA study -. Circ J 83:1747\u20131754. https:\/\/doi.org\/10.1253\/circj.CJ-19-0186","journal-title":"Circ J"},{"key":"2713_CR36","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.ahj.2015.02.006","volume":"169","author":"A Masri","year":"2015","unstructured":"Masri A, Pierson LM, Smedira NG, Agarwal S, Lytle BW, Naji P et al (2015) Predictors of long-term outcomes in patients with hypertrophic cardiomyopathy undergoing cardiopulmonary stress testing and echocardiography. Am Heart J 169:684-692.e1. https:\/\/doi.org\/10.1016\/j.ahj.2015.02.006","journal-title":"Am Heart J"},{"issue":"Suppl 1","key":"2713_CR37","first-page":"133","volume":"37","author":"Y Doi","year":"2001","unstructured":"Doi Y, Kitaoka H (2001) Hypertrophic cardiomyopathy in the elderly: significance of atrial fibrillation. J Cardiol 37(Suppl 1):133\u2013138","journal-title":"J Cardiol"},{"key":"2713_CR38","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/s00380-020-01728-4","volume":"36","author":"H Hayashi","year":"2021","unstructured":"Hayashi H, Iwasaki YK, Arai T et al (2021) Prognostic impact of newly detected atrial fibrillation in patients with hypertrophic cardiomyopathy following cardiac implantable electronic device implantation. Heart Vessels 36:667\u2013674. https:\/\/doi.org\/10.1007\/s00380-020-01728-4","journal-title":"Heart Vessels"},{"key":"2713_CR39","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1253\/jcj.59.329","volume":"59","author":"Y Shigematsu","year":"1995","unstructured":"Shigematsu Y, Hamada M, Mukai M, Matsuoka H, Sumimoto T, Hiwada K (1995) Mechanism of atrial fibrillation and increased incidence of thromboembolism in patients with hypertrophic cardiomyopathy. Jpn Circ J 59:329\u2013336. https:\/\/doi.org\/10.1253\/jcj.59.329","journal-title":"Jpn Circ J"},{"key":"2713_CR40","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.amjmed.2003.09.020","volume":"116","author":"HH Ho","year":"2004","unstructured":"Ho HH, Lee KLF, Lau CP, Tse HF (2004) Clinical characteristics of and long-term outcome in chinese patients with hypertrophic cardiomyopathy. Am J Med 116:19\u201323. https:\/\/doi.org\/10.1016\/j.amjmed.2003.09.020","journal-title":"Am J Med"},{"key":"2713_CR41","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.015294","author":"RK Hughes","year":"2020","unstructured":"Hughes RK, Knott KD, Malcolmson J, Augusto JB, Mohiddin SA, Kellman P et al (2020) Apical hypertrophic cardiomyopathy: the variant less known. J Am Heart Assoc. https:\/\/doi.org\/10.1161\/JAHA.119.015294","journal-title":"J Am Heart Assoc"},{"key":"2713_CR42","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1378\/CHEST.09-1584","volume":"137","author":"GYH Lip","year":"2010","unstructured":"Lip GYH, Nieuwlaat R, Pisters R, Lane DA, Crijns HJGM, Andresen D et al (2010) Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest 137:263\u2013272. https:\/\/doi.org\/10.1378\/CHEST.09-1584","journal-title":"Chest"},{"key":"2713_CR43","doi-asserted-by":"publisher","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","volume":"35","author":"JL Zamorano","year":"2014","unstructured":"Zamorano JL, Anastasakis A, Borger MA, Borggrefe M, Cecchi F, Charron P et al (2014) 2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the task force for the diagnosis and management of hypertrophic cardiomyopathy of the European society of cardiology (ESC). Eur Heart J 35:2733\u20132779. https:\/\/doi.org\/10.1093\/eurheartj\/ehu284","journal-title":"Eur Heart J"},{"key":"2713_CR44","doi-asserted-by":"publisher","first-page":"353","DOI":"10.31083\/J.RCM2202042","volume":"22","author":"D Wan","year":"2021","unstructured":"Wan D, Andrade J, Laksman Z, Wan D, Andrade J, Laksman Z (2021) Thromboembolic risk stratification in atrial fibrillation\u2014beyond clinical risk scores. Rev Cardiovasc Med 22:353\u2013363. https:\/\/doi.org\/10.31083\/J.RCM2202042","journal-title":"Rev Cardiovasc Med"},{"key":"2713_CR45","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1016\/J.CJCA.2020.09.001","volume":"36","author":"JG Andrade","year":"2020","unstructured":"Andrade JG, Aguilar M, Atzema C, Bell A, Cairns JA, Cheung CC et al (2020) The 2020 canadian cardiovascular society\/canadian heart rhythm society comprehensive guidelines for the management of atrial fibrillation. Can J Cardiol 36:1847\u20131948. https:\/\/doi.org\/10.1016\/J.CJCA.2020.09.001","journal-title":"Can J Cardiol"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-022-02713-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11239-022-02713-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-022-02713-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T08:26:07Z","timestamp":1676363167000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11239-022-02713-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,3]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,1]]}},"alternative-id":["2713"],"URL":"https:\/\/doi.org\/10.1007\/s11239-022-02713-6","relation":{},"ISSN":["1573-742X"],"issn-type":[{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,3]]},"assertion":[{"value":"22 September 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable as this study is based on published literature.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}